HK Inno.N to distribute Tamiflu as Roche’s new partner
By Lee, Tak-Sun | translator Alice Kang
24.11.18 05:43:52
가나다라
0
Has distributed Xofluza the previous year… Rises as a distribution powerhouse in relevant markets, including those for COVID-19 vaccine supply, etc
HK Inno.N will be responsible for the domestic distribution of ‘Tamiflu Cap’ in addition to the distribution of the antiviral drug ‘Xofluza.’
The company is expected to gain external growth with the distribution of Tamiflu, which has an annual sales volume of KRW 15 billion.
According to industry sources on the 15th, HK Inno.N sent a letter to its business partners and announced that it will distribute Roche Korea’s Tamiflu Cap. 30/45/75mg from the 14th.
Tamiflu is “the” antiviral flu drug. Its sales were sluggish in 2020 and 2021 during the height of the COVID-19 pandemic, but have risen significantly since last year with the rise of the flu epidemic. Last
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)